Therefore, Huang and colleagues suggested that the suppression of invasion by ECG occurs partly via suppression of the FAK signaling pathway in A549 lung cancer cells [77] and that ECG can be administered as an effective clinical anti-EMT agent in lung cancer patients. The gene discussed is PTK2; the disease is lung cancer.